Catalyst Wire Dossier Catalyst Wire Dossier

INFUSE Bone Graft

Recombinant human bone morphogenetic protein-2 (rhBMP-2) · Medtronic
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for INFUSE Bone Graft, covering 2013-03-19 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions [NA]

See pricing